Dearnaley DP - Search Results

1

Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness.

Woods BS, Sideris E, Sydes MR, Gannon MR, Parmar MKB, Alzouebi M, Attard G, Birtle AJ, Brock S, Cathomas R, Chakraborti PR, Cook A, Cross WR, Dearnaley DP, Gale J, Gibbs S, Graham JD, Hughes R, Jones RJ, Laing R, Mason MD, Matheson D, McLaren DB, Millman R, O'Sullivan JM, Parikh O, Parker CC, Peedell C, Protheroe A, Ritchie AWS, Robinson A, Russell JM, Simms MS, Srihari NN, Srinivasan R, Staffurth JN, Sundar S, Thalmann GN, Tolan S, Tran ATH, Tsang D, Wagstaff J, James ND, Sculpher MJ. Woods BS, et al. Among authors: dearnaley dp. Eur Urol Oncol. 2018 Dec;1(6):449-458. doi: 10.1016/j.euo.2018.06.004. Epub 2018 Sep 14. Eur Urol Oncol. 2018. PMID: 31158087 Free PMC article. Clinical Trial.

2

Use of carboplatin in germ cell tumors of the testis.

Horwich A, Mason M, Dearnaley DP. Horwich A, et al. Among authors: dearnaley dp. Semin Oncol. 1992 Feb;19(1 Suppl 2):72-7. Semin Oncol. 1992. PMID: 1329224 Review.

3

The activity of single-agent carboplatin in advanced seminoma.

Horwich A, Dearnaley DP, A'Hern R, Mason M, Thomas G, Jay G, Nicholls J. Horwich A, et al. Among authors: dearnaley dp. Eur J Cancer. 1992;28A(8-9):1307-10. doi: 10.1016/0959-8049(92)90505-v. Eur J Cancer. 1992. PMID: 1515239

4

Hormonal cytoreduction and radiotherapy for carcinoma of the prostate.

Shearer RJ, Davies JH, Gelister JS, Dearnaley DP. Shearer RJ, et al. Among authors: dearnaley dp. Br J Urol. 1992 May;69(5):521-4. doi: 10.1111/j.1464-410x.1992.tb15601.x. Br J Urol. 1992. PMID: 1535824

5

Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors.

Horwich A, Dearnaley DP, Nicholls J, Jay G, Mason M, Harland S, Peckham MJ, Hendry WF. Horwich A, et al. Among authors: dearnaley dp. J Clin Oncol. 1991 Jan;9(1):62-9. doi: 10.1200/JCO.1991.9.1.62. J Clin Oncol. 1991. PMID: 1702147 Clinical Trial.

6

A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer.

Quilty PM, Kirk D, Bolger JJ, Dearnaley DP, Lewington VJ, Mason MD, Reed NS, Russell JM, Yardley J. Quilty PM, et al. Among authors: dearnaley dp. Radiother Oncol. 1994 Apr;31(1):33-40. doi: 10.1016/0167-8140(94)90411-1. Radiother Oncol. 1994. PMID: 7518932 Clinical Trial.

7

Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostatic cancer: preliminary report of a multicenter trial. UK Metastron Investigators Group.

Bolger JJ, Dearnaley DP, Kirk D, Lewington VJ, Mason MD, Quilty PM, Reed NS, Russell JM, Yardley J. Bolger JJ, et al. Among authors: dearnaley dp. Semin Oncol. 1993 Jun;20(3 Suppl 2):32-3. Semin Oncol. 1993. PMID: 7684863 Clinical Trial. No abstract available.

8

Radiotherapy of prostate cancer: established results and new developments.

Dearnaley DP. Dearnaley DP. Semin Surg Oncol. 1995 Jan-Feb;11(1):50-9. doi: 10.1002/ssu.2980110108. Semin Surg Oncol. 1995. PMID: 7754276 Review.

9

The use of bisphosphonates in prostatic cancer.

Mason MD, Glaholm J, Dearnaley DP. Mason MD, et al. Among authors: dearnaley dp. Clin Oncol (R Coll Radiol). 1994;6(2):77-8. doi: 10.1016/s0936-6555(05)80107-4. Clin Oncol (R Coll Radiol). 1994. PMID: 8018576 No abstract available.

10

Cancer of the prostate.

Dearnaley DP. Dearnaley DP. BMJ. 1994 Mar 19;308(6931):780-4. doi: 10.1136/bmj.308.6931.780. BMJ. 1994. PMID: 8142838 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

344 results

Search Page

Filters